Price Statistics
The NADAC for CAPSAICIN 0.1% CREAM has been published 160 times since May 10, 2023, and over the history we have for it it has risen 12.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2018 per GM |
|---|---|
| All-time high | $0.2332 (Oct 16, 2024) |
| All-time low | $0.1528 (Nov 22, 2023) |
| 52-week high | $0.2018 |
| 52-week low | $0.1797 |
| Median price | $0.1884 |
| Average price | $0.1898 |
| Largest weekly change | +38.7% (Sep 18, 2024) |
| Weeks tracked | 160 |
| Tracking since | May 10, 2023 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CAPSAICIN 0.1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for CAPSAICIN 0.1% CREAM, manufactured by AvPAK, is $0.2018 per GM (NDC 50268019842), effective Aug 19, 2026.
How has the price of CAPSAICIN 0.1% CREAM changed over time?
Over the history we have for it, the NADAC for CAPSAICIN 0.1% CREAM has risen 12.8%. It has been tracked across 160 weekly CMS publications since May 10, 2023.
What are the highest and lowest recorded NADAC prices for CAPSAICIN 0.1% CREAM?
Since May 10, 2023, the NADAC for CAPSAICIN 0.1% CREAM has ranged from a low of $0.1528 (Nov 22, 2023) to a high of $0.2332 (Oct 16, 2024), with a median of $0.1884 per GM.
Are there cheaper alternatives to CAPSAICIN 0.1% CREAM?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CAPSAICIN 0.1% CREAM in a comparable dosage form, but none are currently priced below it.
Who manufactures CAPSAICIN 0.1% CREAM?
CAPSAICIN 0.1% CREAM (NDC 50268019842) is labeled by AvPAK, and CMS classifies it as a generic product.